Adipose-Derived Stromal/Stem Cells (ASC) in Regenerative Medicine: Pharmaceutical Applications
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
332-339
Author(s):
Jeffrey M. Gimble and Mark E. Nuttall
Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
560-568
Author(s):
Hong Shen and Carl G. Maki
Recent Advances in the Therapeutic Perspectives of Nutlin-3
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
569-577
Author(s):
Paola Secchiero, Raffaella Bosco, Claudio Celeghini and Giorgio Zauli
Peptide Activators of the p53 Tumor Suppressor
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
603-609
Author(s):
Changyou Zhan and Wuyuan Lu
p53 Activation by Blocking Snail : A Novel Pharmacological Strategy for Cancer
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
610-617
Author(s):
Sun-Hye Lee and Bum-Joon Park
Pharmacological Activation of p53 in Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
631-639
Author(s):
Mohammad Athar, Craig A. Elmets and Levy Kopelovich
Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
191-201
Author(s):
Nadine Hempel, Pauline M. Carrico and J. Andres Melendez
Texaphyrins: Tumor Localizing Redox Active Expanded Porphyrins
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
222-232
Author(s):
Jonathan F. Arambula, Christian Preihs, Derric Borthwick, Darren Magda and Jonathan L. Sessler
The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
242-246
Author(s):
James J. Driscoll, Alex Minter, Daniel A. Driscoll and Jason K. Burris
HIV-1 Infected Patients have Antibodies Recognizing Folded Tat
Journal:
Infectious Disorders - Drug Targets
Volume:
11
Page:
57-63
Author(s):
Sonia Mediouni, Gilbert Baillat, Albert Darque, Isabelle Ravaux and Erwann Loret